0001209191-17-059638.txt : 20171107 0001209191-17-059638.hdr.sgml : 20171107 20171107172638 ACCESSION NUMBER: 0001209191-17-059638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171103 FILED AS OF DATE: 20171107 DATE AS OF CHANGE: 20171107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 171184485 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-03 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2017-11-03 4 M 0 2155 91.05 A 43043 D Common Stock 2017-11-03 4 S 0 2155 150.00 D 40888 D Common Stock 2017-11-06 4 M 0 4250 77.31 A 45138 D Common Stock 2017-11-06 4 S 0 4250 150.00 D 40888 D Common Stock 5306 I 401(k) Stock Option (Right to Buy) 91.05 2017-11-03 4 M 0 2155 0.00 D 2026-02-01 Common Stock 2155 19397 D Stock Option (Right to Buy) 77.31 2017-11-06 4 M 0 4250 0.00 D 2024-02-04 Common Stock 4250 4250 D Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 2/5/2014. /s/ Omar White, Attorney-in-Fact 2017-11-07